Evidence map›Paper›PMID 30697274›Full record

ArticleArchives of medical science : AMS2019

Mohd Fahami Nur Azlina, Hj Mohd Saad Qodriyah, Muhamad Nurul Akmal, Ibrahim Abdel Aziz Ibrahim, Yusof Kamisah

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Bioactive-RichBiomedicines · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Potential Active Constituents fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Frontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mohd Fahami Nur AzlinaDepartment of Pharmacology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia.
Hj Mohd Saad QodriyahDepartment of Pharmacology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia.
Muhamad Nurul AkmalDepartment of Pharmacology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia.
Ibrahim Abdel Aziz IbrahimCollege of Medicine, Umm Al Qura University, Makkah, Saudi Arabia.
Yusof KamisahDepartment of Pharmacology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia.
National University of Malaysia · MYUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMATERIAL AND

methodsThe methanolic extract of PS was prepared in the dose of 500 mg/kg. Twenty-eight male Wistar rats were assigned to 4 equal sized groups: two control groups and two treated groups which were supplemented with either PS or OMZ orally at a dose of 500 mg/kg and 20 mg/kg body weight respectively. After 28 days of treatment, one control group, the PS and OMZ group were subjected to a single exposure of water-immersion restraint stress for 3.5 h. After the last exposure to stress, the stomach was excised for evaluation of the parameters.

resultsOral supplementation of PS was as effective in preventing the formation of gastric lesion when compared with OMZ (

conclusions

Indexed as

gastric ulcersoxidative stressPiper sarmentosumprostaglandinsstress

Identifiers

PMID30697274
PMCPMC6348366
OpenAlexW2544041928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.